Yong Quan

Title: Yong Quan - Innovator in SNORF Receptor Research

Introduction

Yong Quan is a notable inventor based in Fords, NJ (US). He has made significant contributions to the field of molecular biology, particularly in the study of SNORF receptors. His innovative work has led to the development of a patent that addresses important aspects of receptor biology.

Latest Patents

Yong Quan holds a patent for "Processes for obtaining compounds employing SNORF72 receptors." This invention provides isolated nucleic acids encoding mammalian SNORF62 and SNORF72 receptors, as well as purified versions of these receptors. The patent also includes vectors comprising nucleic acid encoding these receptors, cells containing such vectors, and antibodies directed to them. Additionally, it outlines methods for isolating these receptors and treating abnormalities linked to their activity. The patent encompasses a range of applications, including the identification of agonists and antagonists of SNORF62 and SNORF72 receptors.

Career Highlights

Yong Quan is currently associated with H. Lundbeck A/S, where he continues to advance research in receptor biology. His work has been instrumental in understanding the mechanisms of SNORF receptors and their potential therapeutic applications. With a total of 1 patent, his contributions are recognized in the scientific community.

Collaborations

Yong has collaborated with esteemed colleagues such as James A Bonini and Gabriel S Lerman. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Yong Quan's work in the field of SNORF receptors exemplifies the impact of innovative research on medical science. His contributions continue to pave the way for advancements in understanding receptor biology and developing new therapeutic strategies.